Metabolomics reveals that tumor xenografts induce liver dysfunction

Molecular and Cellular Proteomics

Volumn 12, Issue 8, 2013, Pages 2126-2135

  Li, Fei ^a   Patterson, Andrew D ^a,b   Krausz, Kristopher W ^a   Jiang, Changtao ^a   Bi, Huichang ^a   Sowers, Anastasia L ^a   Cook, John A ^a   Mitchell, James B ^a   Gonzalez, Frank J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA,20ALPHA DIHYDROXY 3 OXOPREGN 4 EN 21 OIC ACID; ALBUMIN; CYTOCHROME P450; GLOBULIN; GLYCINE DERIVATIVE; HEXANOYLGLYCINE; MESSENGER RNA; N(G),N(G) DIMETHYLARGININE; NICOTINAMIDE; PREGNANE DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CITRIC ACID CYCLE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FATTY ACID OXIDATION; FEMALE; HEPATOMEGALY; LIVER DYSFUNCTION; METABOLOMICS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR XENOGRAFT; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS; ANIMAL; C3H MOUSE; GENE EXPRESSION; GENETICS; LIVER DISEASE; METABOLISM; PATHOLOGY; TUMOR VOLUME; XENOGRAFT;

ANIMALS; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION; LIVER DISEASES; METABOLOMICS; MICE; MICE, INBRED C3H; TRANSPLANTATION, HETEROLOGOUS; TUMOR BURDEN;

EID: 84881092517     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M113.028324     Document Type: Article

References (37)

1. Chen, C., Krausz, K. W., Shah, Y. M., Idle, J. R., and Gonzalez, F. J. (2009) Serum metabolomics reveals irreversible inhibition of fatty acid betaoxidation through the suppression of PPARalpha activation as a contributing mechanism of acetaminophen-induced hepatotoxicity. Chem. Res. Toxicol. 22, 699-707
2. Li, F., Patterson, A. D., Krausz, K. W., Dick, B., Frey, F. J., Gonzalez, F. J., and Idle, J. R. (2012) Metabolomics reveals the metabolic map of procainamide in humans and mice. Biochem. Pharmacol. 83, 1435-1444
3. Li, F., Patterson, A. D., Krausz, K. W., Tanaka, N., and Gonzalez, F. J. (2012) Metabolomics reveals an essential role for peroxisome proliferator-Activated receptor alpha in bile acid homeostasis. J. Lipid Res. 53, 1625-1635
4. Patterson, A. D., Bonzo, J. A., Li, F., Krausz, K. W., Eichler, G. S., Aslam, S., Tigno, X., Weinstein, J. N., Hansen, B. C., Idle, J. R., and Gonzalez, F. J. (2011) Metabolomics reveals attenuation of the SLC6A20 kidney transporter in nonhuman primate and mouse models of type 2 diabetes mellitus. J. Biol. Chem. 286, 19511-19522
5. Monteiro, M. S., Carvalho, M., Bastos, M. D., and de Pinho, P. G. (2013) Metabolomics analysis for biomarker discovery: advances and challenges. Curr. Med. Chem. 19, 5601-5606
6. Sreekumar, A., Poisson, L. M., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J., Laxman, B., Mehra, R., Lonigro, R. J., Li, Y., Nyati, M. K., Ahsan, A., Kalyana-Sundaram, S., Han, B., Cao, X., Byun, J., Omenn, G. S., Ghosh, D., Pennathur, S., Alexander, D. C., Berger, A., Shuster, J. R., Wei, J. T., Varambally, S., Beecher, C., and Chinnaiyan, A. M. (2009) Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457, 910-914
7. Nam, H., Chung, B. C., Kim, Y., Lee, K., and Lee, D. (2009) Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification. Bioinformatics 25, 3151-3157
8. Xie, G. X., Chen, T. L., Qiu, Y. P., Shi, P., Zheng, X. J., Su, M. M., Zhao, A. H., Zhou, Z. T., and Jia, W. (2012) Urine metabolite profiling offers potential early diagnosis of oral cancer. Metabolomics 8, 220-231
9. Chen, F., Xue, J., Zhou, L., Wu, S., and Chen, Z. (2011) Identification of serum biomarkers of hepatocarcinoma through liquid chromatography/ mass spectrometry-based metabonomic method. Anal. Bioanal. Chem. 401, 1899-1904
10. Chen, T., Xie, G., Wang, X., Fan, J., Qiu, Y., Zheng, X., Qi, X., Cao, Y., Su, M., Xu, L. X., Yen, Y., Liu, P., and Jia, W. (2011) Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma. Mol. Cell. Proteomics 10, M1004945
11. Cheng, Y., Xie, G., Chen, T., Qiu, Y., Zou, X., Zheng, M., Tan, B., Feng, B., Dong, T., He, P., Zhao, L., Zhao, A., Xu, L. X., Zhang, Y., and Jia, W. (2012) Distinct urinary metabolic profile of human colorectal cancer. J. Proteome Res. 11, 1354-1363
12. Ganti, S., Taylor, S. L., Abu Aboud, O., Yang, J., Evans, C., Osier, M. V., Alexander, D. C., Kim, K., and Weiss, R. H. (2012) Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysis. Cancer Res. 72, 3471-3479
13. Li, S., Liu, H., Jin, Y., Lin, S., Cai, Z., and Jiang, Y. (2011) Metabolomics study of alcohol-induced liver injury and hepatocellular carcinoma xenografts in mice. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879, 2369-2375
14. Moroz, J., Turner, J., Slupsky, C., Fallone, G., and Syme, A. (2011) Tumour xenograft detection through quantitative analysis of the metabolic profile of urine in mice. Phys. Med. Biol. 56, 535-556
15. Wang, X., Yan, S. K., Dai, W. X., Liu, X. R., Zhang, W. D., and Wang, J. J. (2010) A metabonomic approach to chemosensitivity prediction of cisplatin plus 5-fluorouracil in a human xenograft model of gastric cancer. Int. J. Cancer 127, 2841-2850
16. Cotrim, A. P., Hyodo, F., Matsumoto, K., Sowers, A. L., Cook, J. A., Baum, B. J., Krishna, M. C., and Mitchell, J. B. (2007) Differential radiation protection of salivary glands versus tumor by Tempol with accompanying tissue assessment of Tempol by magnetic resonance imaging. Clin. Cancer Res. 13, 4928-4933
17. Zhen, Y., Krausz, K. W., Chen, C., Idle, J. R., and Gonzalez, F. J. (2007) Metabolomic and genetic analysis of biomarkers for peroxisome proliferator- activated receptor alpha expression and activation. Mol. Endocrinol. 21, 2136-2151
18. Downing, M., Manning, N. J., Dalton, R. N., Krywawych, S., and Oerton, J. (2008) Detection of urinary hexanoylglycine in the diagnosis of MCAD deficiency from newborn screening. J. Inherit. Metab. Dis. 31, 550
19. Boger, R. H. (2005) Asymmetric dimethylarginine (ADMA) and cardiovascular disease: insights from prospective clinical trials. Vasc. Med. 10 Suppl 1, S19-S25
20. Wang, D., Strandgaard, S., Iversen, J., and Wilcox, C. S. (2009) Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296, R195-R200
21. Korandji, C., Zeller, M., Guilland, J. C., Collin, B., Lauzier, B., Sicard, P., Duvillard, L., Goirand, F., Moreau, D., Cottin, Y., Rochette, L., and Vergely, C. (2011) Time course of asymmetric dimethylarginine (ADMA) and oxidative stress in fructose-hypertensive rats: a model related to metabolic syndrome. Atherosclerosis 214, 310-315
22. Pavlides, S., Tsirigos, A., Migneco, G., Whitaker-Menezes, D., Chiavarina, B., Flomenberg, N., Frank, P. G., Casimiro, M. C., Wang, C., Pestell, R. G., Martinez-Outschoorn, U. E., Howell, A., Sotgia, F., and Lisanti, M. P. (2010) The autophagic tumor stroma model of cancer: role of oxidative stress and ketone production in fueling tumor cell metabolism. Cell Cycle 9, 3485-3505
23. Redon, C. E., Dickey, J. S., Nakamura, A. J., Kareva, I. G., Naf, D., Nowsheen, S., Kryston, T. B., Bonner, W. M., Georgakilas, A. G., and Sedelnikova, O. A. (2010) Tumors induce complex DNA damage in distant proliferative tissues in vivo. Proc. Natl. Acad. Sci. U.S.A. 107, 17992-17997
24. Kim, K. B., Yang, J. Y., Kwack, S. J., Park, K. L., Kim, H. S., Ryu do, H., Kim, Y. J., Hwang, G. S., and Lee, B. M. (2010) Toxicometabolomics of urinary biomarkers for human gastric cancer in a mouse model. J. Toxicol. Environ. Health A 73, 1420-1430
25. Somashekar, B. S., Kamarajan, P., Danciu, T., Kapila, Y. L., Chinnaiyan, A. M., Rajendiran, T. M., and Ramamoorthy, A. (2011) Magic angle spinning NMR-based metabolic profiling of head and neck squamous cell carcinoma tissues. J. Proteome Res. 10, 5232-5241
26. Furusawa, M., Onomichi, M., Morishita, S., Hamatake, S., Takahashi, M., and Ito, Y. H. (1997) Carbon-13 magnetic resonance spectroscopy of glucose metabolism in SCC-VIII tumors. Radiat. Med. 15, 149-153
27. Matsumoto, S., Saito, K., Yasui, H., Morris, H. D., Munasinghe, J. P., Lizak, M., Merkle, H., Ardenkjaer-Larsen, J. H., Choudhuri, R., Devasahayam, N., Subramanian, S., Koretsky, A. P., Mitchell, J. B., and Krishna, M. C. (2013) EPR oxygen imaging and hyperpolarized (13) C MRI of pyruvate metabolism as noninvasive biomarkers of tumor treatment response to a glycolysis inhibitor 3-bromopyruvate. Magn. Reson. Med. 69, 1443-1450
28. Hartong, D. T., Dange, M., Mcgee, T. L., Berson, E. L., Dryja, T. P., and Colman, R. F. (2008) Insights from retinitis pigmentosa into the roles of isocitrate dehydrogenases in the Krebs cycle. Nat. Genet. 40, 1230-1234
29. Prensner, J. R., and Chinnaiyan, A. M. (2011) Metabolism unhinged: IDH mutations in cancer. Nat. Med. 17, 291-293
30. Patterson, A. D., Li, H., Eichler, G. S., Krausz, K. W., Weinstein, J. N., Fornace, A. J., Jr., Gonzalez, F. J., and Idle, J. R. (2008) UPLC-ESITOFMS- based metabolomics and gene expression dynamics inspector self-organizing metabolomic maps as tools for understanding the cellular response to ionizing radiation. Anal. Chem. 80, 665-674
31. Lorimore, S. A., Coates, P. J., Scobie, G. E., Milne, G., and Wright, E. G. (2001) Inflammatory-type responses after exposure to ionizing radiation in vivo: a mechanism for radiation-induced bystander effects? Oncogene 20, 7085-7095
32. Morgan, E. T. (1997) Regulation of cytochromes P450 during inflammation and infection. Drug Metab. Rev. 29, 1129-1188
33. Robertson, G. R., Liddle, C., and Clarke, S. J. (2008) Inflammation and altered drug clearance in cancer: transcriptional repression of a human CYP3A4 transgene in tumor-bearing mice. Clin. Pharmacol. Ther. 83, 894-897
34. Sharma, R., Kacevska, M., London, R., Clarke, S. J., Liddle, C., and Robertson, G. (2008) Downregulation of drug transport and metabolism in mice bearing extra-hepatic malignancies. Br. J. Cancer 98, 91-97
35. Zhang, Y., Li, F., Patterson, A. D., Wang, Y., Krausz, K. W., Neale, G., Thomas, S., Nachagari, D., Vogel, P., Vore, M., Gonzalez, F. J., and Schuetz, J. D. (2012) Abcb11 deficiency induces cholestasis coupled to impaired beta-fatty acid oxidation in mice. J. Biol. Chem. 287, 24784-24794
36. Moolenaar, W. H. (1999) Bioactive lysophospholipids and their G proteincoupled receptors. Exp. Cell Res. 253, 230-238
37. Matsubara, T., Tanaka, N., Patterson, A. D., Cho, J. Y., Krausz, K. W., and Gonzalez, F. J. (2011) Lithocholic acid disrupts phospholipid and sphingolipid homeostasis leading to cholestasis in mice. Hepatology 53, 1282-1293